CVS CVS Health Corporation Common Stock
关于 CVS Health Corporation Common Stock 公司概况(来自维基百科)
CVS健康公司 是一家美国医疗保健公司,总部位于罗得岛州文索基特,旗下有CVS藥局、CVS Caremark、安泰人壽等多个品牌。2021年,该公司在财富美国500强中排名第4,在财富世界500强中排名第7。
阅读更多
CVS健康公司(CVS Health Corporation;原名CVS Corporation、CVS Caremark Corporation)是一家美国医疗保健公司,总部位于罗得岛州文索基特,旗下有CVS藥局、CVS Caremark、安泰人壽等多个品牌。2021年,该公司在财富美国500强中排名第4,在财富世界500强中排名第7。
## 历史
1963年,消费者价值商店(Consumer Value Stores)在马萨诸塞州洛厄尔成立,主要销售美容产品。1969年,它被梅尔维尔公司(Melville Corporation)收购,1996年自梅尔维尔公司拆分,在纽约证券交易所上市。
2018年11月,它以690亿美元的价格收购安泰人壽。
来源:维基百科, CC BY-SA 4.0 · 在维基百科上查看 ↗
CVS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
CVS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 |
|---|---|
| 2026年7月23日 | $0.6650 |
| 2026年4月23日 | $0.6650 |
| 2026年1月22日 | $0.6650 |
| 2025年10月23日 | $0.6650 |
| 2025年7月22日 | $0.6650 |
| 2025年4月22日 | $0.6650 |
| 2025年1月23日 | $0.6650 |
| 2024年10月21日 | $0.6650 |
| 2024年7月22日 | $0.6650 |
| 2024年4月19日 | $0.6650 |
| 2024年1月19日 | $0.6650 |
| 2023年10月19日 | $0.6050 |
| 2023年7月20日 | $0.6050 |
| 2023年4月20日 | $0.6050 |
| 2023年1月19日 | $0.6050 |
| 2022年10月20日 | $0.5500 |
| 2022年7月21日 | $0.5500 |
| 2022年4月21日 | $0.5500 |
| 2022年1月20日 | $0.5500 |
| 2021年10月21日 | $0.5000 |
CVS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 8 24.2%
- 买入 20 60.6%
- 持有 5 15.2%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
25 位分析师 · 2026-08-17收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $2.58 | $1.87 | 0.71% |
| 2026年3月31日 | $2.57 | $2.22 | 0.35% |
| 2025年12月31日 | $1.09 | $1.00 | 0.09% |
| 2025年9月30日 | $1.60 | $1.38 | 0.22% |
| 2025年6月30日 | $1.81 | $1.47 | 0.34% |
| 2025年3月31日 | $2.25 | $1.72 | 0.53% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Cost of Revenue | $221.17B | $206.29B | $217.10B | $196.89B | $175.80B | $163.98B | $158.72B | · | $153.45B | $146.53B | $126.76B | |
| Gross Profit | · | · | · | · | · | · | · | · | $28.55B | $28.86B | $26.53B | |
| Operating Expenses | $397.41B | $364.29B | $344.03B | $314.51B | $278.80B | $254.79B | $244.79B | · | $18.81B | $18.45B | $17.05B | |
| Operating Income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B | $11.99B | · | $9.54B | $10.39B | $9.47B | |
| Interest Expense | · | · | $2.66B | $2.29B | $2.50B | $2.91B | $3.04B | · | $1.06B | $1.08B | $859M | |
| Interest Income | · | · | · | · | · | · | · | · | $21M | $20M | $21M | |
| Other Non-op | $112M | $99M | $88M | $169M | $182M | $206M | $124M | · | $-208M | $-28M | · | |
| Pretax Income | $2.14B | $6.15B | $11.17B | $5.84B | $10.54B | $9.77B | $9.00B | · | $8.27B | $8.64B | $8.62B | |
| Income Tax | $408M | $1.56B | $2.81B | $1.51B | $2.55B | $2.57B | $2.37B | · | $1.64B | $3.32B | $3.39B | |
| Net Income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| EPS (Basic) | $1.40 | $3.67 | $6.49 | $3.29 | $6.07 | $5.48 | $5.10 | · | $6.47 | $4.93 | $4.66 | |
| EPS (Diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | · | $6.44 | $4.90 | $4.63 | |
| Shares (Basic) | 1,267,000,000 | 1,259,000,000 | 1,285,000,000 | 1,312,000,000 | 1,319,000,000 | 1,309,000,000 | 1,301,000,000 | · | 1,020,000,000 | 1,073,000,000 | 1,118,000,000 | |
| Shares (Diluted) | 1,271,000,000 | 1,262,000,000 | 1,290,000,000 | 1,323,000,000 | 1,329,000,000 | 1,314,000,000 | 1,305,000,000 | · | 1,024,000,000 | 1,079,000,000 | 1,126,000,000 | |
| EBITDA | $9.27B | $13.11B | $18.11B | $11.99B | $17.70B | $18.35B | $16.36B | · | $12.00B | $10.34B | $9.45B |
资产负债表 31
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.45B | $8.59B | $8.20B | $12.95B | $9.41B | $7.85B | $5.68B | · | $1.70B | $3.37B | $2.46B | |
| Short-term Investments | $2.15B | $2.41B | $3.26B | $2.78B | $3.12B | $3.00B | $2.37B | · | $111M | $87M | $88M | |
| Receivables | $39.78B | $36.47B | $35.23B | $27.28B | $24.43B | $21.74B | $19.62B | · | $13.18B | $12.16B | $11.89B | |
| Inventory | $19.25B | $18.11B | $18.02B | $19.09B | $17.76B | $18.50B | $17.52B | · | $15.30B | $14.76B | $14.00B | |
| Other Current Assets | $5.09B | $3.08B | $3.15B | $2.64B | $5.29B | $5.28B | $5.11B | $4.53B | $945M | $660M | $722M | |
| Current Assets | $74.71B | $68.64B | $67.86B | $65.63B | $60.01B | $56.37B | $50.30B | $45.20B | $31.23B | $31.04B | $29.16B | |
| PP&E (Net) | · | · | · | $12.87B | $12.90B | $12.61B | $12.04B | $11.36B | $10.29B | $10.18B | $9.86B | |
| PP&E (Gross) | · | · | · | $34.60B | $33.55B | $31.31B | $28.93B | · | $24.29B | $22.80B | $21.04B | |
| Accum. Depreciation | · | · | · | $21.48B | $20.65B | $18.70B | $16.89B | · | $14.00B | $12.63B | $11.18B | |
| Goodwill | $85.48B | $91.27B | $91.27B | $78.15B | $79.12B | $79.55B | $79.75B | · | $38.45B | $38.25B | $38.11B | |
| Intangibles | $25.51B | $27.32B | $29.23B | $24.80B | $29.03B | $31.14B | $33.12B | $36.31B | $13.63B | $13.51B | $13.88B | |
| Other Non-current Assets | $7.11B | $4.79B | $4.66B | $4.62B | $4.71B | $4.62B | $4.60B | $4.53B | $1.42B | $1.49B | $1.44B | |
| Total Assets | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | $216.67B | $95.13B | $94.46B | $92.44B | |
| Accounts Payable | · | · | · | · | · | · | · | · | $8.86B | $7.95B | $7.49B | |
| Accrued Liabilities | $22.39B | $20.81B | $23.52B | $18.75B | $17.67B | $14.24B | $12.13B | $10.66B | $6.58B | $6.94B | $6.83B | |
| Short-term Debt | $0 | $2.12B | $200M | $0 | · | $0 | $0 | · | $1.28B | $1.87B | $0 | |
| Current Liabilities | $88.69B | $84.61B | $79.19B | $69.42B | $67.81B | $62.02B | $53.30B | $45.76B | $30.65B | $26.25B | $23.17B | |
| Capital Leases | $13.64B | $14.90B | $16.03B | $16.80B | $18.18B | $18.76B | $18.93B | $18.83B | $306M | · | · | |
| Deferred Tax | $3.83B | $3.81B | $4.31B | $4.02B | $6.27B | $6.79B | $7.29B | $7.74B | $3.00B | $4.21B | $4.22B | |
| Other Non-current Liabilities | $6.77B | $5.43B | $6.21B | $6.73B | $1.90B | $2.35B | $2.16B | $2.26B | $1.28B | $1.55B | $1.54B | |
| Total Liabilities | $178.16B | $177.49B | $173.09B | $156.51B | $157.62B | $161.01B | $158.28B | $157.95B | $57.44B | · | · | |
| Long-term Debt | · | · | · | · | · | · | $68.48B | $72.61B | $27.00B | $25.70B | $27.50B | |
| Total Debt | $0 | $2.12B | $200M | · | · | · | $3.78B | · | $27.00B | $27.53B | $27.46B | |
| Common Stock | · | $18M | $18M | $18M | $17M | $17M | $17M | · | $17M | $17M | $17M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $32.08B | $31.62B | $30.95B | |
| Retained Earnings | $61.20B | $62.84B | $61.60B | $56.40B | $54.91B | $49.64B | $45.11B | $41.09B | $43.56B | $38.98B | $35.51B | |
| Treasury Stock | $36.79B | $36.82B | $33.84B | $31.86B | $28.17B | $28.18B | $28.23B | · | $37.80B | $33.45B | $28.89B | |
| AOCI | $406M | $-120M | $-297M | $-1.26B | $965M | $1.41B | $1.02B | · | $-165M | $-305M | $-358M | |
| Stockholders' Equity | $75.21B | $75.56B | $76.46B | $71.47B | $75.08B | $69.39B | $63.86B | $58.40B | $37.69B | $36.83B | $37.20B | |
| Liabilities + Equity | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | · | $95.13B | $94.46B | $92.44B | |
| Shares Outstanding | 1,271,000,000 | 1,260,000,000 | 1,288,000,000 | 1,300,000,000 | 1,322,000,000 | 1,310,000,000 | 1,302,000,000 | · | 1,712,000,000 | 1,061,000,000 | 1,101,000,000 |
现金流 19
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.61B | $4.60B | $4.37B | $4.22B | $4.49B | $4.44B | $4.37B | · | $2.48B | $2.48B | $2.09B | |
| Stock-based Comp | $535M | $540M | $588M | $447M | $484M | $400M | $453M | · | $234M | $222M | $230M | |
| Deferred Tax | $102M | $-572M | $-676M | $-2.03B | $-402M | $-564M | $-649M | · | $-1.42B | $3M | $-234M | |
| Amort. of Intangibles | $2.00B | $2.00B | $1.90B | $1.80B | $2.20B | $2.30B | $2.40B | · | $817M | $795M | $611M | |
| Restructuring | · | · | · | · | · | · | · | · | $215M | · | · | |
| Other Non-cash | $3.63B | $-72M | $804M | $9.41B | $5.79B | $4.41B | $2.04B | · | $93M | · | · | |
| Operating Cash Flow | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B | $15.87B | $12.85B | · | $8.01B | $10.14B | $8.54B | |
| CapEx | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B | $2.44B | $2.46B | · | $1.92B | $2.22B | $2.37B | |
| Investing Cash Flow | $-5.87B | $-7.61B | $-20.89B | $-5.05B | $-5.26B | $-5.53B | $-3.34B | · | $-2.88B | $-2.47B | $-13.42B | |
| Debt Issued | $3.97B | $7.91B | $10.90B | $0 | $987M | $9.96B | $3.74B | · | $0 | $3.46B | $14.80B | |
| Net Debt Issued | $340M | $3.14B | $7.73B | $-4.21B | $-9.27B | $-5.67B | $-4.60B | · | · | $-2.49B | $11.90B | |
| Stock Repurchased | $0 | $3.02B | $2.01B | $3.50B | $0 | $0 | $0 | · | $4.36B | $4.46B | $5.00B | |
| Net Stock Activity | $0 | $-3.02B | $-2.01B | $-3.50B | · | · | $0 | · | $-4.36B | $-4.46B | $-5.00B | |
| Dividends Paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B | |
| Financing Cash Flow | $-4.94B | $-1.14B | $2.68B | $-10.52B | $-11.36B | $-7.70B | $-7.65B | · | $-6.75B | $-6.76B | $4.88B | |
| Net Change in Cash | $-172M | $359M | $-4.78B | $614M | $1.65B | $2.63B | $1.85B | · | $-1.62B | $912M | $-22M | |
| Taxes Paid | $2.17B | $1.70B | $3.52B | $4.12B | $3.19B | $2.93B | $2.72B | · | $2.91B | $3.06B | $3.27B | |
| Free Cash Flow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B | $13.43B | $10.39B | · | $6.09B | $7.84B | $6.04B | |
| Levered FCF | · | · | $8.40B | $11.76B | $13.85B | $11.29B | $8.15B | · | $5.24B | $7.18B | $5.52B |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 15.4% | 16.3% | 17.3% | |
| Operating Margin | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% | 5.2% | 4.7% | · | 5.1% | 5.8% | 6.2% | |
| Net Margin | 0.44% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | · | 3.6% | 3.0% | 3.4% | |
| Pretax Margin | 0.53% | 1.7% | 3.1% | 1.8% | 3.6% | 3.6% | 3.5% | · | 4.5% | 4.9% | 5.6% | |
| EBITDA Margin | 2.3% | 3.5% | 5.1% | 3.7% | 6.1% | 6.8% | 6.4% | · | 6.5% | 5.8% | 6.2% | |
| ROA | 0.70% | 1.8% | 3.5% | 1.8% | 3.4% | 3.2% | 3.0% | · | 7.0% | 5.7% | 6.2% | |
| ROE | 2.4% | 6.1% | 11.3% | 5.7% | 10.9% | 10.8% | 10.8% | · | 17.8% | 14.4% | 13.9% | |
| ROIC | 5.0% | 8.2% | 13.4% | 8.1% | 13.3% | 14.8% | 13.1% | · | 11.8% | 9.9% | 8.9% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.2 | 1.3 | |
| Quick Ratio | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | · | · | · | 0.1 | · | 0.7 | 0.7 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.7 | 0.7 | |
| Interest Coverage | · | · | 5.2 | 3.4 | 5.3 | 4.8 | 3.9 | · | 9.0 | 9.6 | 11.0 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.2 | 1.2 | · | 1.9 | 1.9 | 1.8 | |
| Inventory Turnover | 11.8 | 11.4 | 11.7 | 10.7 | 9.7 | 9.1 | 9.3 | · | 10.4 | 10.3 | 9.8 | |
| Receivables Turnover | 10.5 | 10.4 | 11.4 | 12.5 | 12.7 | 13.0 | 13.8 | · | 14.6 | 14.8 | 14.2 |
增长率 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.8% | 4.2% | 10.9% | 10.4% | 8.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.6% | 8.5% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -62.0% | -43.4% | 98.5% | -45.9% | 10.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -24.7% | -15.3% | 5.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -23.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -61.7% | -44.7% | 93.5% | -46.1% | 11.5% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -25.7% | -16.8% | 5.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -24.4% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Net Income TTM | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| Market Cap | $100.87B | $56.56B | $101.70B | $121.15B | $136.38B | $89.47B | $96.73B | · | $73.52B | $83.72B | $107.64B | |
| Enterprise Value | $90.27B | $47.69B | $90.45B | · | · | · | $92.45B | · | $98.71B | $107.80B | $132.56B | |
| P/E | 57.1 | 12.3 | 12.2 | 28.6 | 17.1 | 12.5 | 14.6 | · | 11.3 | 16.1 | 21.1 | |
| P/S | 0.3 | 0.2 | 0.3 | 0.4 | 0.5 | 0.3 | 0.4 | · | 0.4 | 0.5 | 0.7 | |
| P/B | 1.3 | 0.7 | 1.3 | 1.7 | 1.8 | 1.3 | 1.5 | · | 2.0 | 2.3 | 2.9 | |
| P / Cash Flow | 9.5 | 6.2 | 7.6 | 7.5 | 7.5 | 5.6 | 7.5 | · | 9.2 | 8.3 | 12.8 | |
| P / FCF | 12.9 | 8.9 | 9.8 | 9.0 | 8.7 | 6.7 | 9.3 | · | 12.1 | 10.7 | 17.8 | |
| EV / EBITDA | 9.7 | 3.6 | 5.0 | · | · | · | 5.7 | · | 8.2 | 10.4 | 14.0 | |
| EV / FCF | 11.6 | 7.5 | 8.7 | · | · | · | 8.9 | · | 16.2 | 13.7 | 21.9 | |
| EV / Revenue | 0.2 | 0.1 | 0.3 | · | · | · | 0.4 | · | 0.5 | 0.6 | 0.9 | |
| Dividend Yield | 3.4% | 6.0% | 3.1% | 2.4% | 1.9% | 2.9% | 2.7% | · | 2.8% | 2.2% | 1.5% | |
| Earnings Yield | 1.8% | 8.2% | 8.2% | 3.5% | 5.8% | 8.0% | 6.8% | · | 8.9% | 6.2% | 4.7% | |
| Payout Ratio | 192.1% | 73.1% | 37.5% | 70.1% | 33.2% | 36.5% | 39.2% | · | 30.9% | 34.6% | 30.1% | |
| Annual Payout | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | $94.59B | $97.71B | $95.43B | $91.23B | $88.44B | $93.81B | $89.76B | $88.92B | $85.28B | $83.85B | $81.16B | |
| Cost of Revenue | $58.86B | $55.44B | $59.06B | $57.05B | $54.01B | $51.06B | $55.27B | $52.95B | $50.00B | $48.07B | $57.42B | $54.69B | $53.54B | $51.45B | $51.73B | $50.37B | |
| Operating Expenses | $101.39B | $95.75B | $103.58B | $106.08B | $96.53B | $91.21B | $95.34B | $94.60B | $88.19B | $86.17B | $90.44B | $86.07B | $85.69B | $81.83B | $80.19B | $85.08B | |
| Operating Income | $4.70B | $4.68B | $2.11B | $-3.21B | $2.38B | $3.37B | $2.37B | $832M | $3.04B | $2.27B | $3.37B | $3.69B | $3.23B | $3.45B | $3.66B | $-3.92B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $716M | · | $693M | $686M | $589M | · | $566M | |
| Other Non-op | $31M | $32M | $29M | $26M | $29M | $28M | $25M | $25M | $24M | $25M | $22M | $22M | $22M | $22M | $43M | $41M | |
| Pretax Income | $3.98B | $3.94B | $1.35B | $-3.48B | $1.65B | $2.62B | $2.13B | $105M | $2.34B | $1.58B | $2.71B | $3.02B | $2.57B | $2.88B | $3.15B | $-4.44B | |
| Income Tax | $982M | $981M | $-1.57B | $508M | $634M | $835M | $503M | $34M | $569M | $456M | $658M | $754M | $656M | $737M | $818M | $-1.04B | |
| Net Income | $2.98B | $2.94B | $2.94B | $-3.98B | $1.02B | $1.78B | $1.64B | $87M | $1.77B | $1.11B | $2.05B | $2.26B | $1.90B | $2.14B | $2.33B | $-3.41B | |
| EPS (Basic) | $2.33 | $2.31 | $2.31 | $-3.13 | $0.81 | $1.41 | $1.31 | $0.07 | $1.41 | $0.88 | $1.59 | $1.76 | $1.48 | $1.66 | $1.78 | $-2.59 | |
| EPS (Diluted) | $2.31 | $2.30 | $2.31 | $-3.13 | $0.80 | $1.41 | $1.30 | $0.07 | $1.41 | $0.88 | $1.59 | $1.75 | $1.48 | $1.65 | $1.79 | $-2.59 | |
| Shares (Basic) | 1,279,000,000 | 1,273,000,000 | -2,529,000,000 | 1,269,000,000 | 1,266,000,000 | 1,261,000,000 | -2,516,000,000 | 1,259,000,000 | 1,256,000,000 | 1,260,000,000 | -2,568,000,000 | 1,287,000,000 | 1,283,000,000 | 1,283,000,000 | -2,628,000,000 | 1,315,000,000 | |
| Shares (Diluted) | 1,287,000,000 | 1,279,000,000 | -2,532,000,000 | 1,269,000,000 | 1,270,000,000 | 1,264,000,000 | -2,523,000,000 | 1,259,000,000 | 1,259,000,000 | 1,267,000,000 | -2,578,000,000 | 1,290,000,000 | 1,287,000,000 | 1,291,000,000 | -2,641,000,000 | 1,315,000,000 | |
| EBITDA | $5.83B | $5.79B | · | $-2.07B | $3.55B | $4.53B | · | $832M | $3.04B | $3.41B | · | $3.69B | $3.23B | $4.45B | · | $-3.93B |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | $10.08B | $8.59B | $6.88B | $12.51B | $9.80B | $8.20B | $13.04B | $13.81B | $14.62B | $12.95B | $17.20B | |
| Short-term Investments | $2.63B | $2.26B | $2.15B | $2.13B | $2.39B | $2.58B | $2.41B | $2.81B | $3.75B | $3.29B | · | $3.15B | $3.08B | $3.10B | · | $2.79B | |
| Receivables | $40.31B | $40.99B | $39.78B | $43.86B | $40.65B | $39.62B | $36.47B | $36.18B | $32.38B | $32.22B | · | $32.93B | $29.55B | $28.33B | · | $26.32B | |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | $17.39B | $18.11B | $17.65B | $16.07B | $16.35B | · | $17.95B | $17.29B | $18.26B | · | $18.06B | |
| Other Current Assets | $3.46B | $4.25B | $5.09B | $3.06B | $3.38B | $3.53B | $3.08B | $3.83B | $5.24B | $5.82B | · | $3.07B | $3.41B | $3.77B | · | $2.48B | |
| Current Assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | $73.19B | $68.64B | $67.34B | $69.95B | $67.47B | · | $70.14B | $67.76B | $68.71B | · | $68.34B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $13.02B | $13.00B | $12.87B | · | $12.63B | |
| Goodwill | $85.48B | $85.48B | $85.48B | $85.48B | $91.20B | $91.20B | $91.27B | $91.27B | $91.27B | $91.27B | $91.27B | $91.26B | $91.26B | $84.06B | $78.15B | $78.09B | |
| Intangibles | $24.64B | $25.07B | $25.51B | $25.98B | $26.22B | $26.57B | $27.32B | $27.82B | $28.31B | $28.77B | · | $29.62B | $30.12B | $26.37B | · | $25.16B | |
| Other Non-current Assets | $7.43B | $7.42B | $5.12B | $5.16B | $5.21B | $5.23B | $4.79B | $4.76B | $4.80B | $4.80B | · | $4.83B | $4.85B | $4.82B | · | $4.85B | |
| Total Assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Accrued Liabilities | $22.48B | $22.26B | $22.39B | $23.41B | $23.10B | $22.37B | $20.81B | $20.17B | $21.16B | $22.35B | · | $22.57B | $22.83B | $21.52B | · | $19.42B | |
| Short-term Debt | · | · | $0 | $1.25B | $3.04B | $1.26B | $2.12B | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Current Liabilities | $87.04B | $86.41B | $88.69B | $92.69B | $94.16B | $88.96B | $84.61B | $84.63B | $81.39B | $83.32B | · | $81.55B | $79.21B | $75.05B | · | $72.41B | |
| Capital Leases | $12.98B | $13.33B | $13.64B | $14.01B | $14.33B | $14.59B | $14.90B | $15.26B | $15.54B | $15.74B | · | $16.44B | $16.61B | $16.57B | · | $17.17B | |
| Deferred Tax | $3.77B | $3.77B | $3.83B | $3.55B | $3.60B | $3.66B | $3.81B | $3.63B | $4.05B | $4.18B | · | $4.25B | $4.59B | $4.09B | · | $3.51B | |
| Other Non-current Liabilities | $6.11B | $6.71B | $4.78B | $4.76B | $4.78B | $5.42B | $5.43B | $5.48B | $5.53B | $6.21B | · | $6.24B | $6.32B | $6.67B | · | $6.77B | |
| Total Liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | $178.47B | $177.49B | $177.32B | $177.37B | $175.59B | · | $176.80B | $177.07B | $167.75B | · | $160.20B | |
| Total Debt | · | · | · | $1.25B | $3.04B | $1.26B | · | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Common Stock | · | · | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | $18M | $18M | |
| Retained Earnings | $65.40B | $63.28B | $61.20B | $59.11B | $63.94B | $63.77B | $62.84B | $62.04B | $62.80B | $61.87B | · | $60.34B | $58.87B | $57.75B | · | $54.57B | |
| Treasury Stock | $36.85B | $36.71B | $36.79B | $36.78B | $36.85B | $36.73B | $36.82B | $36.81B | $36.92B | $36.77B | · | $33.83B | $33.93B | $33.80B | · | $30.33B | |
| AOCI | $188M | $201M | $406M | $416M | $272M | $59M | $-120M | $209M | $-319M | $-341M | · | $-1.00B | $-858M | $-875M | · | $-1.61B | |
| Stockholders' Equity | $79.70B | $77.46B | $75.21B | $72.93B | $77.38B | $76.93B | $75.56B | $74.94B | $74.93B | $73.97B | · | $74.34B | $72.73B | $71.38B | · | $70.68B | |
| Liabilities + Equity | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Shares Outstanding | 1,278,000,000 | 1,273,000,000 | 1,271,000,000 | 1,270,000,000 | 1,267,000,000 | 1,262,000,000 | 1,260,000,000 | 1,258,000,000 | 1,256,000,000 | 1,252,000,000 | · | 1,287,000,000 | 1,282,000,000 | 1,279,000,000 | · | 1,315,000,000 |
现金流 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.13B | $1.11B | $1.15B | $1.13B | $1.17B | $1.15B | $1.15B | $1.16B | $1.15B | $1.14B | $1.13B | $1.13B | $1.10B | $1.00B | $1.04B | $1.04B | |
| Stock-based Comp | $176M | $266M | $135M | $138M | $136M | $126M | $137M | $133M | $133M | $137M | $127M | $154M | $204M | $103M | $106M | $105M | |
| Amort. of Intangibles | $431M | $442M | $507M | $500M | $494M | $499M | $478M | $507M | $507M | $508M | $504M | $509M | $485M | $402M | $420M | $458M | |
| Other Non-cash | · | $-75M | · | · | · | $1.50B | · | · | · | $2.52B | · | · | · | $4.20B | · | · | |
| Operating Cash Flow | $6.34B | $4.25B | $3.39B | $796M | $1.90B | $4.56B | $1.86B | $-745M | $3.09B | $4.90B | $-2.64B | $2.72B | $5.91B | $7.44B | $-1.95B | $9.12B | |
| CapEx | $691M | $849M | $784M | $698M | $607M | $743M | $768M | $670M | $638M | $705M | $911M | $545M | $591M | $984M | $688M | $580M | |
| Investing Cash Flow | $-1.88B | $-874M | $-2.00B | $-2.09B | $-1.02B | $-762M | $-547M | $-3.35B | $-1.62B | $-2.09B | $-1.24B | $-771M | $-10.36B | $-8.51B | $-119M | $-805M | |
| Debt Issued | · | · | $0 | $3.97B | · | · | $2.95B | $0 | $4.96B | $0 | $0 | $0 | $4.95B | $5.95B | $0 | $0 | |
| Net Debt Issued | · | $-1.52B | · | · | · | $-743M | · | · | · | $-18M | · | · | · | $5.59B | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $0 | $0 | $0 | $-1M | $-3M | $3.03B | $-1M | $-3M | $-2M | $2.02B | $1.50B | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-3.03B | · | · | · | $-2.02B | · | · | |
| Dividends Paid | $878M | $847M | $845M | $846M | $866M | $840M | $838M | $837M | $858M | $840M | $779M | $779M | $795M | $779M | $719M | $726M | |
| Financing Cash Flow | $-2.69B | $-2.32B | $-2.03B | $-1.38B | $806M | $-2.33B | $431M | $-1.59B | $1.25B | $-1.23B | $-972M | $-2.70B | $3.63B | $2.73B | $-2.19B | $-3.22B | |
| Net Change in Cash | $1.77B | $1.06B | $-640M | $-2.67B | $1.68B | $1.46B | $1.74B | $-5.68B | $2.71B | $1.58B | $-4.85B | $-752M | $-828M | $1.65B | $-4.26B | $5.10B | |
| Taxes Paid | $374M | $-337M | $998M | $305M | $725M | $138M | $274M | $700M | $666M | $63M | $908M | $837M | $1.70B | $75M | $1.05B | $1.18B | |
| Free Cash Flow | · | $3.40B | · | · | · | $3.81B | · | · | · | $4.20B | · | · | · | $6.45B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $3.69B | · | · | · | $6.02B | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.4% | 4.7% | · | -3.1% | 2.4% | 3.6% | · | 0.87% | 3.3% | 2.6% | · | 4.1% | 3.6% | 4.0% | · | -4.8% | |
| Net Margin | 2.8% | 2.9% | · | -3.9% | 1.0% | 1.9% | · | 0.09% | 1.9% | 1.3% | · | 2.5% | 2.1% | 2.5% | · | -4.2% | |
| Pretax Margin | 3.8% | 3.9% | · | -3.4% | 1.7% | 2.8% | · | 0.11% | 2.6% | 1.8% | · | 3.4% | 2.9% | 3.4% | · | -5.5% | |
| EBITDA Margin | 5.5% | 5.8% | · | -2.0% | 3.6% | 4.8% | · | 0.87% | 3.3% | 3.9% | · | 4.1% | 3.6% | 5.2% | · | -4.8% | |
| ROA | 1.2% | 1.2% | · | -1.6% | 0.40% | 0.70% | · | 0.03% | 0.70% | 0.46% | · | 0.94% | 0.79% | 0.90% | · | -1.5% | |
| ROE | 3.8% | 3.8% | · | -5.4% | 1.3% | 2.4% | · | 0.12% | 2.4% | 1.5% | · | 3.1% | 2.6% | 2.9% | · | -4.7% | |
| ROIC | 4.4% | 4.5% | · | -5.0% | 1.8% | 2.9% | · | 0.74% | 3.1% | 2.1% | · | 3.7% | 3.3% | 3.6% | · | -4.2% |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | 5.3 | 4.7 | 5.9 | · | -6.9 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Inventory Turnover | 3.4 | 3.2 | · | 3.1 | 3.2 | 3.0 | · | 3.0 | 3.0 | 2.8 | · | 3.0 | 3.1 | 2.8 | · | 2.8 | |
| Receivables Turnover | 2.6 | 2.5 | · | 2.6 | 2.7 | 2.6 | · | 2.8 | 2.9 | 2.9 | · | 3.0 | 3.1 | 3.1 | · | 3.1 |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $408.31B | $396.80B | · | $391.80B | $380.17B | $369.69B | · | $364.86B | $358.36B | $352.40B | · | $345.12B | $335.99B | $323.90B | · | $312.42B | |
| Net Income TTM | $2.97B | $1.77B | · | $-1.09B | $4.66B | $4.75B | · | $5.23B | $7.04B | $7.41B | · | $2.89B | $3.66B | $4.11B | · | $3.58B | |
| Market Cap | $132.21B | $91.43B | · | $95.75B | $87.40B | $85.50B | · | $79.10B | $74.18B | $99.86B | · | $89.86B | $88.62B | $95.04B | · | $125.41B | |
| Enterprise Value | · | · | · | $85.76B | $76.26B | $74.11B | · | $70.22B | $57.92B | $89.49B | · | · | $72.74B | · | · | · | |
| P/E | 45.4 | 52.0 | · | -88.7 | 18.7 | 18.0 | · | 15.3 | 10.7 | 13.8 | · | 30.5 | 24.4 | 23.8 | · | 35.7 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| P/B | 1.7 | 1.2 | · | 1.3 | 1.1 | 1.1 | · | 1.1 | 1.0 | 1.4 | · | 1.2 | 1.2 | 1.3 | · | 1.8 | |
| P / Cash Flow | · | 21.5 | · | · | · | 18.8 | · | · | · | 20.4 | · | · | · | 12.8 | · | · | |
| P / FCF | · | 26.9 | · | · | · | 22.4 | · | · | · | 23.8 | · | · | · | 14.7 | · | · | |
| EV / EBITDA | · | · | · | -41.4 | 21.5 | 16.4 | · | 84.4 | 19.0 | 26.3 | · | · | 22.5 | · | · | · | |
| EV / FCF | · | · | · | · | · | 19.4 | · | · | · | 21.3 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | · | 0.2 | · | · | · | |
| Earnings Yield | 2.2% | 1.9% | · | -1.1% | 5.3% | 5.6% | · | 6.5% | 9.3% | 7.2% | · | 3.3% | 4.1% | 4.2% | · | 2.8% | |
| Payout Ratio | · | 28.8% | · | · | · | 47.2% | · | · | · | 75.5% | · | · | · | 36.5% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B |
| 营业利润率 % | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% |
| 净收入 | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B |
| 稀释后每股收益 (EPS) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.0 | 0.0 | 0.0 | — | — |
| 流动比率 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 |
| 速动比率 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B |
最新新闻 提及该公司的近期头条新闻
交易信号 近期买入/卖出信号,包含入场价和风险/回报比
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 2292 家申报者 · $77.0B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 319 (+131 与上一季度对比) | 93 (-97 与上一季度对比) | 783 (+85 与上一季度对比) | 714 (-58 与上一季度对比) | +184.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $8618974924 | 83315369 | 11.20% | 股份 |
| Capital World Investors | $7753834783 | 74951955 | 10.07% | 股份 |
| STATE STREET CORP | $6236318558 | 60283408 | 8.10% | 股份 |
| Dodge & Cox | $5173820539 | 50012765 | 6.72% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $3266370439 | 31574388 | 4.24% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2755624444 | 26637259 | 3.58% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $2646473316 | 25714722 | 3.44% | 股份 |
| Capital Research Global Investors | $2516851376 | 24329151 | 3.27% | 股份 |
| NORGES BANK | $1866126481 | 18038922 | 2.42% | 股份 |
| FMR LLC | $1684924609 | 16287333 | 2.19% | 股份 |
| Capital International Investors | $1591868430 | 15387600 | 2.07% | 股份 |
| Davis Selected Advisers | $1227594458 | 11865916 | 1.59% | 股份 |
| Clearbridge Investments, LLC | $878119687 | 8488349 | 1.14% | 股份 |
| GQG Partners LLC | $822989370 | 7955411 | 1.07% | 股份 |
| AMERIPRISE FINANCIAL INC | $761355564 | 7357966 | 0.99% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $741242940 | 7165229 | 0.96% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $643180166 | 6217304 | 0.84% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $524415257 | 5069263 | 0.68% | 股份 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $499125457 | 4824799 | 0.65% | 股份 |
| CITADEL ADVISORS LLC | $493765609 | 4772988 | 0.64% | 股份 |
| VIKING GLOBAL INVESTORS LP | $378974695 | 3663361 | 0.49% | 股份 |
| Swiss National Bank | $371195152 | 3588160 | 0.48% | 股份 |
| BlackRock, Inc. | $364982048 | 3528101 | 0.47% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $354997941 | 3431590 | 0.46% | 股份 |
| National Pension Service | $352166145 | 3404216 | 0.46% | 股份 |
| ROYAL BANK OF CANADA | $338495000 | 3272060 | 0.44% | 股份 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $322653390 | 3118927 | 0.42% | 股份 |
| GOLDMAN SACHS GROUP INC | $319964422 | 3092938 | 0.42% | 股份 |
| Legal & General Group Plc | $315302980 | 3047878 | 0.41% | 股份 |
| Holocene Advisors, LP | $310524210 | 3001684 | 0.40% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $300309006 | 2902944 | 0.39% | 股份 |
| CITADEL ADVISORS LLC | $299591200 | 2896000 | 0.39% | 买入期权 |
| Sumitomo Mitsui Trust Group, Inc. | $298855050 | 2888884 | 0.39% | 股份 |
| Vanguard Global Advisers, LLC | $295578375 | 2857210 | 0.38% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $295497373 | 2856427 | 0.38% | 股份 |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | $280502160 | 2712000 | 0.36% | 股份 |
| CITADEL ADVISORS LLC | $267076865 | 2581700 | 0.35% | 卖出期权 |
| BNP PARIBAS FINANCIAL MARKETS | $261748880 | 2530197 | 0.34% | 股份 |
| BANK OF AMERICA CORP /DE/ | $249417276 | 2410993 | 0.32% | 股份 |
| PRIMECAP MANAGEMENT CO/CA/ | $246778944 | 2385490 | 0.32% | 股份 |
| RHUMBLINE ADVISERS | $246744475 | 2385158 | 0.32% | 股份 |
| FRANKLIN RESOURCES INC | $238592528 | 2306356 | 0.31% | 股份 |
| California Public Employees Retirement System | $233879967 | 2260802 | 0.30% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $232194060 | 3233000 | 0.30% | 股份 |
| JANE STREET GROUP, LLC | $231055575 | 2233500 | 0.30% | 卖出期权 |
| CANADA PENSION PLAN INVESTMENT BOARD | $230615292 | 2229244 | 0.30% | 股份 |
| Canoe Financial LP | $226952024 | 2193833 | 0.29% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $223951974 | 2164833 | 0.29% | 股份 |
| VANGUARD GROUP INC | $222935255 | 2809164 | 0.29% | 股份 |
| UBS Group AG | $221527830 | 2141400 | 0.29% | 买入期权 |
| Brandywine Global Investment Management, LLC | $216103153 | 2723074 | 0.28% | 股份 |
| Robeco Institutional Asset Management B.V. | $207806227 | 2008760 | 0.27% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $205293939 | 1984475 | 0.27% | 股份 |
| Point72 Asset Management, L.P. | $202868760 | 1961032 | 0.26% | 股份 |
| JANUS HENDERSON GROUP PLC | $200732734 | 2794942 | 0.26% | 股份 |
| JANE STREET GROUP, LLC | $190306620 | 1839600 | 0.25% | 买入期权 |
| JONES FINANCIAL COMPANIES LLLP | $186577346 | 1788167 | 0.24% | 股份 |
| Assenagon Asset Management S.A. | $183757718 | 1776295 | 0.24% | 股份 |
| MACKENZIE FINANCIAL CORP | $177786480 | 1718574 | 0.23% | 股份 |
| Hamlin Capital Management, LLC | $177686548 | 1717608 | 0.23% | 股份 |
| Alyeska Investment Group, L.P. | $174358768 | 1685440 | 0.23% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $169576171 | 1639209 | 0.22% | 股份 |
| LPL Financial LLC | $160912185 | 1555458 | 0.21% | 股份 |
| PRUDENTIAL FINANCIAL INC | $156319985 | 1511068 | 0.20% | 股份 |
| GOLDMAN SACHS GROUP INC | $153033585 | 1479300 | 0.20% | 买入期权 |
| Quantinno Capital Management LP | $150197267 | 1451882 | 0.20% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $149812359 | 1448162 | 0.19% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $146277266 | 1413990 | 0.19% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $143800879 | 1390052 | 0.19% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $143310113 | 1385308 | 0.19% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $135669704 | 1889024 | 0.18% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $133185771 | 1287441 | 0.17% | 股份 |
| BARCLAYS PLC | $130962631 | 1265951 | 0.17% | 股份 |
| UBS Group AG | $130742593 | 1263824 | 0.17% | 股份 |
| MACQUARIE GROUP LTD | $130222860 | 1258800 | 0.17% | 股份 |
| Patient Capital Management, LLC | $127813106 | 1235505 | 0.17% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $125407000 | 1212248 | 0.16% | 股份 |
| Maple Rock Capital Partners Inc. | $123932686 | 1197996 | 0.16% | 股份 |
| BANK OF MONTREAL /CAN/ | $120915774 | 1168833 | 0.16% | 股份 |
| Qube Research & Technologies Ltd | $118745083 | 1147850 | 0.15% | 股份 |
| TD Asset Management Inc | $117174298 | 1132666 | 0.15% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $114781970 | 1108148 | 0.15% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $114360975 | 1105471 | 0.15% | 股份 |
| AVIVA PLC | $113872588 | 1100750 | 0.15% | 股份 |
| Integral Health Asset Management, LLC | $113795000 | 1100000 | 0.15% | 股份 |
| LETKO, BROSSEAU & ASSOCIATES INC | $113305164 | 1095265 | 0.15% | 股份 |
| TRUIST FINANCIAL CORP | $112799640 | 1090378 | 0.15% | 股份 |
| Woodline Partners LP | $112125214 | 1083859 | 0.15% | 股份 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $111580653 | 1078595 | 0.14% | 股份 |
| STOREBRAND ASSET MANAGEMENT AS | $111494582 | 1077763 | 0.14% | 股份 |
| NORDEA INVESTMENT MANAGEMENT AB | $110986994 | 1076081 | 0.14% | 股份 |
| BANK OF NOVA SCOTIA | $103790874 | 1003295 | 0.13% | 股份 |
| Capital International, Inc./CA/ | $102952716 | 995193 | 0.13% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $100146711 | 970080 | 0.13% | 股份 |
| Walleye Trading LLC | $98691300 | 954000 | 0.13% | 买入期权 |
| Walleye Trading LLC | $98049910 | 947800 | 0.13% | 卖出期权 |
| Korea Investment CORP | $97590385 | 943358 | 0.13% | 股份 |
| JENNISON ASSOCIATES LLC | $97539798 | 942869 | 0.13% | 股份 |
| SEB Asset Management AB | $96760081 | 935333 | 0.13% | 股份 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $91910670 | 888455 | 0.12% | 股份 |
公司内部人士 86 位内幕人士 · 48 位高管 · 41 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| David J. Joyner | President, CEO and Chair | 2026年4月1日 F | 70349 | 0 | 0 | $0 |
| Karen S Lynch | President and CEO | 2024年4月1日 A | 74687 | 0 | 0 | $0 |
| Brian Newman | EVP, Chief Financial Officer | 2026年5月31日 F | 3008 | 0 | 0 | $0 |
| Thomas F. Cowhey | EVP and CFO | 2025年4月1日 A | 41109 | 0 | 0 | $0 |
| Shawn M Guertin | EVP & Chief Financial Officer | 2023年4月1日 A | 34706 | 0 | 0 | $0 |
| Eva C Boratto | EVP & CFO | 2021年5月4日 S | 115331 | 0 | 0 | $0 |
| David M Denton | EVP and CFO | 2018年11月29日 S | 403 | 0 | 0 | $0 |
| David B Rickard | Chief Financial Officer | 2009年12月14日 M | 207179 | 0 | 0 | $0 |
| Howard A Mclure | President, Caremark Pharm Serv | 2009年11月2日 M | 0 | 0 | 0 | $0 |
| Jonathan C Roberts | EVP & Chief Operating Officer | 2022年4月1日 A | 426025 | 0 | 0 | $0 |
| James David Clark | SVP, Cont & Chief Acct Officer | 2026年6月26日 F | 27606 | 0 | 0 | $0 |
| Amy Compton-Phillips | EVP, Chief Medical Officer | 2026年5月31日 F | 9557 | 0 | 0 | $0 |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | 2026年5月8日 S | 10133 | 0 | 1 | $-6230379 |
| Prem S Shah | EVP and Group President | 2026年3月31日 A | 64356 | 0 | 0 | $0 |
| Heidi B Capozzi | EVP and Chief People Officer | 2026年3月31日 A | 13023 | 3 | 0 | $4588 |
| Samrat S. Khichi | EVP, CPO and General Counsel | 2026年3月31日 A | 33421 | 0 | 0 | $0 |
| Steven H Nelson | EVP and President, Aetna | 2026年3月31日 A | 2900 | 1 | 0 | $1289 |
| Sreekanth K Chaguturu | EVP and Chief Medical Officer | 2024年4月1日 A | 23666 | 0 | 0 | $0 |
| Laurie P. Havanec | EVP and Chief People Officer | 2024年4月1日 A | 9426 | 0 | 0 | $0 |
| Brian A Kane | EVP/President, Aetna | 2024年4月1日 A | 12569 | 0 | 0 | $0 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | 2023年4月1日 A | 35068 | 0 | 0 | $0 |
| Michelle A Peluso | EVP and Co-President of Retail | 2023年4月1日 A | 124383 | 0 | 0 | $0 |
| Thomas M Moriarty | EVP & General Counsel | 2022年12月31日 F | 315273 | 0 | 0 | $0 |
| Alan Lotvin | EVP&President-PharmacyServices | 2022年8月4日 M | 109183 | 0 | 0 | $0 |
| Troyen A Brennan | EVP and Chief Medical Officer | 2022年4月3日 F | 232676 | 0 | 0 | $0 |
| Neela Montgomery | EVP and Pres., Pharmacy/Retail | 2021年4月1日 A | 29502 | 0 | 0 | $0 |
| Lisa Bisaccia | Former EVP & Chief HR Officer | 2021年4月1日 F | 66417 | 0 | 0 | $0 |
| Joshua Matthew Flum | EVP, ENT STRATEGY & DIGITAL | 2021年2月28日 F | 25657 | 0 | 0 | $0 |
| Jonathan E. Mayhew | EVP - Transformation | 2020年12月2日 F | 6855 | 0 | 0 | $0 |
| Derica W Rice | EVP & President, CVS Caremark | 2020年2月28日 F | 26827 | 0 | 0 | $0 |
| Kevin Hourican | EVP & President, CVS Pharmacy | 2019年4月1日 A | 15237 | 0 | 0 | $0 |
| Helena Foulkes | EVP & President-CVS Pharmacy | 2018年2月16日 M | 45107 | 0 | 0 | $0 |
| Robert O. Kraft | EVP and President - Omnicare | 2017年4月3日 A | 92360 | 0 | 0 | $0 |
| Andrew Sussman | EVP, Clinical Services | 2017年4月3日 A | 16433 | 0 | 0 | $0 |
| Stephen J Gold | EVP & CIO | 2017年4月3日 A | 46818 | 0 | 0 | $0 |
| Per Gh Lofberg | EVP | 2015年1月2日 M | 23419 | 0 | 0 | $0 |
| Mark Cosby | EVP & President-CVS/pharmacy | 2013年9月30日 M | 45955 | 0 | 0 | $0 |
| Laird Daniels | SVP, Cont & Chief Acct Officer | 2013年4月1日 A | 17845 | 0 | 0 | $0 |
| Douglas A Sgarro | EVP and CLO | 2012年5月11日 M | 214 | 0 | 0 | $0 |
| Stuart M Mcguigan | SVP and CIO | 2012年3月16日 M | 10967 | 0 | 0 | $0 |
| Thomas M Ryan | Non-Executive Chairman | 2011年4月3日 F | 1156702 | 0 | 0 | $0 |
| Sara Finley | SVP, Gen Counsel | 2011年2月18日 F | 29053 | 0 | 0 | $0 |
| Michael V Ferdinandi | Senior Vice President | 2009年8月19日 S | 16021 | 0 | 0 | $0 |
| Paula A Price | Controller | 2008年2月12日 A | 16498 | 0 | 0 | $0 |
| Edwin M Crawford | Chairman | 2007年10月29日 A | 135572 | 0 | 0 | $0 |
| William R Spalding | EVP Caremark Pharmacy Services | 2007年6月18日 M | 182 | 0 | 0 | $0 |
| Gregory S Weishar | Vice President | 2006年4月3日 A | 30161 | 0 | 0 | $0 |
| Larry D Solberg | Senior Vice President | 2006年2月16日 A | 5978 | 0 | 0 | $0 |
| ROBBINS LARRY | 董事 | 2026年5月21日 S | 4824799 | 0 | 8 | $-352750556 |
| Fernando Aguirre | 董事 | 2026年5月21日 D | 10513 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| CVS Caremark Corporation | 2011年1月7日 | — | 初始申报 | 并购/出售 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 218 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IHF · iShares Trust | 13.66% | 1756753 SH | 2026年8月8日 | 每日 |
| ROPE · EA Series Trust | 5.27% | 4922 NS | 2026年5月29日 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 4.57% | 636042 NS | 2026年4月30日 | N-PORT |
| IYK · iShares Trust | 4.22% | 624816 SH | 2026年8月8日 | 每日 |
| GEND · Spinnaker ETF Series | 3.66% | 1968 NS | 2026年4月30日 | N-PORT |
| PEZ · Invesco Exchange-Traded Fund Trust | 3.42% | 8210 SH | 2026年8月8日 | 每日 |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 2.71% | 3618 NS | 2026年4月30日 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2.58% | 79142 NS | 2026年5月31日 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 2.33% | 158312 NS | 2026年4月30日 | N-PORT |
| SDOG · ALPS ETF Trust | 2.25% | 342879 NS | 2026年5月31日 | N-PORT |
| COWZ · Pacer Funds Trust | 2.16% | 4706232 NS | 2026年4月30日 | N-PORT |
| QQWZ · Pacer Funds Trust | 2.15% | 12078 NS | 2026年4月30日 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trus... | 1.95% | 2024890 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 1.94% | 3824297 SH | 2026年8月8日 | 每日 |
| FXG · First Trust Exchange-Traded Alpha... | 1.89% | 55579 NS | 2026年4月30日 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1.88% | 334242 SH | 2026年8月8日 | 每日 |
| SPDV · ETF Series Solutions | 1.86% | 20100 NS | 2026年4月30日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1.71% | 585200 NS | 2026年4月30日 | N-PORT |
| RXL · ProShares Trust | 1.67% | 13266 NS | 2026年5月31日 | N-PORT |
| IXJ · iShares Trust | 1.55% | 670400 SH | 2026年8月8日 | 每日 |
| REVS · Columbia ETF Trust I | 1.55% | 52621 NS | 2026年4月30日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1.53% | 25368 NS | 2026年4月30日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.48% | 120955 SH | 2026年8月8日 | 每日 |
| SPVM · Invesco Exchange-Traded Fund Trust | 1.45% | 19889 SH | 2026年8月8日 | 每日 |
| PWV · Invesco Exchange-Traded Fund Trust | 1.40% | 261212 SH | 2026年8月8日 | 每日 |
| VLUE · iShares Trust | 1.38% | 1353743 SH | 2026年8月8日 | 每日 |
| DVY · iShares Trust | 1.37% | 3341969 SH | 2026年8月8日 | 每日 |
| ITAN · EA Series Trust | 1.36% | 13295 NS | 2026年5月29日 | N-PORT |
| GKAT · Advisors Series Trust | 1.30% | 27039 NS | 2026年3月31日 | N-PORT |
| GMOV · GMO ETF Trust | 1.21% | 12118 NS | 2026年5月31日 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Inde... | 1.17% | 41394000 | 2026年8月8日 | 每日 |
| GURU · Global X Funds | 1.17% | 8187 NS | 2026年4月30日 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trus... | 1.13% | 16706 NS | 2026年5月31日 | N-PORT |
| SPXD · DBX ETF Trust | 1.12% | 830 NS | 2026年5月31日 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trus... | 1.11% | 31567000 | 2026年8月8日 | 每日 |
| CVAR · ETF Opportunities Trust | 1.01% | 4716 NS | 2026年4月30日 | N-PORT |
| VCEB · VANGUARD WORLD FUND | 0.99% | 12250700 PA | 2026年8月8日 | 每日 |
| CGCV · Capital Group Conservative Equity... | 0.99% | 189872 NS | 2026年5月31日 | N-PORT |
| PALC · Pacer Funds Trust | 0.98% | 27132 NS | 2026年4月30日 | N-PORT |
| ABCS · EA Series Trust | 0.98% | 1219 NS | 2026年5月29日 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 0.97% | 2025 NS | 2026年4月30日 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.95% | 77895 SH | 2026年8月8日 | 每日 |
| EQWL · Invesco Exchange-Traded Fund Trust | 0.92% | 267202 SH | 2026年8月8日 | 每日 |
| FNDX · SCHWAB STRATEGIC TRUST | 0.91% | 2553383 NS | 2026年5月31日 | N-PORT |
| VCLT · VANGUARD SCOTTSDALE FUNDS | 0.91% | 98192000 PA | 2026年8月8日 | 每日 |
| IUS · Invesco Exchange-Traded Self-Inde... | 0.88% | 87427 SH | 2026年8月8日 | 每日 |
| AKAF · ETF Series Solutions | 0.84% | 271 NS | 2026年5月31日 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0.83% | 120850 NS | 2026年5月31日 | N-PORT |
| RECS · Columbia ETF Trust I | 0.81% | 529096 NS | 2026年4月30日 | N-PORT |
| FEUS · FlexShares Trust | 0.81% | 10773 NS | 2026年4月30日 | N-PORT |